IP Verse

Stabilized Modified Release Vitamin D Formulation And Method Of Administering Same

Patent No. EP3650016 (titled "Stabilized Modified Release Vitamin D Formulation And Method Of Administering Same") was filed by Eirgen Pharma on Mar 14, 2014. The application was issued on May 5, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DSM NUTRITIONAL PRODUCTSFeb 7, 2022KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3650016

EIRGEN PHARMA
Application Number
EP19217651A
Filing Date
Mar 14, 2014
Status
Granted And Under Opposition
Apr 3, 2021
Publication Date
May 5, 2021
External Links
Slate, Register , Google Patents